Condition
Vertical Transmission of Infectious Disease
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05705427Phase 4Completed
The COMBAT HBV Feasibility Trial
NCT04883801Completed
Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19
NCT03567382Phase 4Completed
Arresting Vertical Transmission of Hepatitis B Virus
NCT04416373Unknown
COVID-19 and Pregnancy Outcomes
NCT03058484Not ApplicableCompletedPrimary
Community Health Workers and Prevention of Mother-to-Child HIV Transmission in Tanzania
Showing all 5 trials